AstraZeneca Plc’s shares rose after a report that Chief Executive Officer Pascal Soriot wants to move the British drugmaker’s ...

(Reuters) -AstraZeneca CEO Pascal Soriot is considering moving the company's stock market listing to the U.S., the Times ...

AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – ...

AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...

American investors might not have to trade in the company's ADSes in the future. Trading in AstraZeneca's (NASDAQ: AZN) ...

The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

CEO Pascal Soriot has not hidden his annoyance at taxes and regulations the pharmaceutical firm have to navigate ...

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

FTSE 100 giant AstraZeneca is considering moving its listing to the US, marking a potential further blow to the health of ...